In its latest SEC filing, Foundations Investment Advisors LLC disclosed a 93.3% reduction in its position in Intuitive Surgical during the third quarter, selling 37,895 shares and retaining just 2,715 shares. Following the divestiture, the adviser’s remaining stake in the robotic-surgery specialist was valued at approximately 1.21 million. This dramatic cut contrasts with smaller adjustments by other institutions: Strategic Advisors LLC increased its holding by 63.3% to 10,397 shares, AE Wealth Management raised its stake by 18.9% to 11,556 shares and LRI Investments added 387 shares for a 24.0% gain, reflecting divergent views on the company’s near-term growth trajectory.

Intuitive Surgical reported quarterly revenue of 2.87 billion, marking an 18.8% year-over-year increase, and delivered earnings of 2.53 per share, exceeding consensus estimates by 0.26. The company’s net margin stood at 28.38%, while return on equity was 15.06%. This performance was driven by continued strength in system placements and recurring instrument and accessory sales, supporting the firm’s projection of full-year earnings of 6.43 per share. Investors will be watching management’s commentary on procedure growth rates and supply-chain normalization in upcoming conference calls.

Research firms have provided varied assessments of Intuitive Surgical’s outlook. Two analysts maintain a Strong Buy recommendation, fourteen have issued Buy ratings, eight have recommended Hold and one has rated the stock Sell. Recent target adjustments ranged from cuts—from 635 to 590 by Citigroup and from 580 to 550 by Evercore ISI—to upward revisions—from 510 to 550 by Daiwa Capital Markets and from 593 to 600 by Leerink Partners. The consensus target price stands at 620.41, reflecting both optimism about long-term market penetration and caution over valuation multiples given the company’s price-to-earnings ratio above 60.